Voss Capital, LLC, an investment management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. Voss Capital’s funds, Voss Value Fund, LP, and the Voss Value Offshore Fund, Ltd returned -2.1% and -2.2%, respectively, to investors net of fees and expenses, in the fourth quarter compared to a +2.2% return for the Russell 2000 Index, +3.3% return for the Russell 2000 Value Index, and +2.7% return for the S&P 500 Index. The Voss Value Master Fund’s total gross exposure stood at 158.7%, and the delta-adjusted was 78.8% as of December 31, 2025. The weight of the Fund’s top 10 longs was 76.4%, and the top 10 shorts were -27.3%. The letter discussed the storm around Artificial Intelligence. Software companies have the highest AI adoption rates. The firm believes that early users of new technology, rather than infrastructure providers, often receive the largest long-term economic benefits. Incumbent corporations enjoy a structural advantage due to their access to engineering skills and modern multi-agent tools. In addition, you can check the firm’s top 5 holdings to determine its best picks for 2025.
In its fourth-quarter 2025 investor letter, Voss Capital highlighted Cellebrite DI Ltd. (NASDAQ:CLBT). Headquartered in Petah Tikva, Israel, Cellebrite DI Ltd. (NASDAQ:CLBT) is a digital forensics company that offers DI suite of solutions to law enforcement, military and other customers. On March 06, 2026, Cellebrite DI Ltd. (NASDAQ:CLBT) stock closed at $15.30 per share. One-month return of Cellebrite DI Ltd. (NASDAQ:CLBT) was 4.44%, and its shares lost 8.82% over the past 52 weeks. Cellebrite DI Ltd. (NASDAQ:CLBT) has a market capitalization of $3.74 billion.
Voss Capital stated the following regarding Cellebrite DI Ltd. (NASDAQ:CLBT) in its fourth quarter 2025 investor letter:
“On core long Cellebrite DI Ltd.’s (NASDAQ:CLBT) digital forensics turf, there are several major barriers to entry, and the software itself could be considered the least of them. Cellebrite is a hardware-enabled software solution that has become both a verb (to “Cellebrite” a device) and a noun (create a Cellebrite report) for its users across the globe.
A defensible moat for CLBT has been its exploit library. CLBT’s device unlock and extraction capability requires: § Zero-day and N-day exploits for iOS and Android (often acquired from the vulnerability market or developed in-house)
Hardware interposers and chip-off capabilities for physically damaged devices o A forensic technician physically de-solders the memory chip (the “brain” where your photos and messages live) right off the phone’s circuit board. o Once a damaged phone’s chip is removed, it is placed into this interposer. The interposer aligns the tiny, microscopic pins of the chip perfectly so it can be plugged into a forensic workstation. o Cellebrite provides the specific hardware (the adapters) and software (the “translators”) to help investigators make sense of that raw data and, in many cases, use proprietary exploits to help figure out the passcode even when the physical phone is wrecked…” (Click here to read the full text)
Cellebrite DI Ltd. (NASDAQ:CLBT) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 35 hedge fund portfolios held Cellebrite DI Ltd. (NASDAQ:CLBT) at the end of the fourth quarter, up from 31 in the previous quarter. In Q4 2025, Cellebrite DI Ltd.’s (NASDAQ:CLBT) revenue grew 18% year-over-year to $128.8 million. While we acknowledge the risk and potential of Cellebrite DI Ltd. (NASDAQ:CLBT) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than Cellebrite DI Ltd. (NASDAQ:CLBT) and that has 10,000% upside potential, check out our report about this cheapest AI stock.
In another article, we covered Cellebrite DI Ltd. (NASDAQ:CLBT) and shared a list of best growth stocks to buy for the next 20 years. In addition, please check out our hedge fund investor letters Q4 2025 page for more investor letters from hedge funds and other leading investors.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None. This article is originally published at Insider Monkey.
